Irish Journal of Medical Science (1971 -)

, Volume 185, Issue 4, pp 857–863 | Cite as

Cardiac syndrome X in Ireland: incidence and phenotype

Original Article

Abstract

Background

Cardiac syndrome X (CSX) is typical angina pectoris with objective signs of myocardial ischaemia despite a normal coronary angiogram and may be due to microvascular dysfunction. The incidence of CSX has not been greatly investigated worldwide and its incidence in Ireland is unknown.

Aims

We aimed to determine the incidence of CSX in Cork University Hospital (CUH) and to establish the phenotype of the typical Irish CSX patient.

Methods

All patients undergoing coronary angiography in CUH during regular working hours over a 3-month period were investigated. CSX was diagnosed using standard criteria. An extended recruitment period of 14 months allowed enrolment of a sufficient number of CSX patients to enable phenotyping.

Results

Only 5 of 372 (1.3 %) patients undergoing angiography to investigate chest pain met the diagnostic criteria for CSX. None were given a discharge diagnosis of CSX or received cardiology follow-up. Irish CSX patients were predominantly female (88 %) with a mean age of 59.2 ± 6.6 years. Although they were significantly less functionally limited than patients with obstructive CAD, they had an equally substantial impairment in quality of life.

Conclusions

CSX is relatively uncommon in Ireland and is most frequently seen in middle-aged women with hyperlipidaemia. It has significant impacts on patients’ quality of life. None of the CSX patients were diagnosed as such, highlighting the lack of awareness or acceptance of this condition in Ireland. These patients require diagnosis and active cardiology follow-up to effectively manage their symptoms.

Keywords

Angina pectoris Normal coronary arteries Microvascular angina Epidemiology 

Notes

Acknowledgments

JD is in receipt of an academic training fellowship award from the Health Research Board, an agency sponsored by the Irish government. The authors are supported, in part, by Science Foundation Ireland in the form of a centre grant (Alimentary Pharmabiotic Centre) under Grant Number SFI/12/RC/2273.

Compliance with ethical standards

Funding

This study was not directly funded. The main author, JD, is in receipt of a government sponsored academic research training award.

Conflict of interest

The authors report no conflicts of interest in this case.

Ethical approval

The study was approved by the clinical research ethics committee for the Cork teaching hospitals and complied with the 1964 declaration of Helsinki and its later amendments and all participants gave full informed consent.

References

  1. 1.
    Lanza GA, Crea F (2010) Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 121(21):2317–2325. doi: 10.1161/circulationaha.109.900191 CrossRefPubMedGoogle Scholar
  2. 2.
    Dollard J, Kearney P, Clarke G, Moloney G, Cryan JF, Dinan TG (2014) A prospective study of C-reactive protein as a state marker in Cardiac Syndrome X. Brain Behav Immun. doi: 10.1016/j.bbi.2014.07.011 PubMedGoogle Scholar
  3. 3.
    Tousoulis D, Davies GJ, Asimakopoulos G, Homaei H, Zouridakis E, Ahmed N, Kaski JC (2001) Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). Clin Cardiol 24(4):301–304CrossRefPubMedGoogle Scholar
  4. 4.
    Vermeltfoort IA, Teule GJ, van Dijk AB, Muntinga HJ, Raijmakers PG (2012) Long-term prognosis of patients with cardiac syndrome X: a review. Neth Heart J Mon J Neth Soc Cardiol Neth Heart Found 20(9):365–371. doi: 10.1007/s12471-012-0256-z CrossRefGoogle Scholar
  5. 5.
    Vermeltfoort IA, Raijmakers PG, Riphagen II, Odekerken DA, Kuijper AF, Zwijnenburg A, Teule GJ (2010) Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin R Cardiol Off J German Card Soc 99(8):475–481. doi: 10.1007/s00392-010-0159-1 CrossRefGoogle Scholar
  6. 6.
    Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD (1995) Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 25(2):333–341CrossRefPubMedGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2015

Authors and Affiliations

  1. 1.Department of CardiologyCork University HospitalCorkIreland
  2. 2.Department of PsychiatryUniversity College CorkCorkIreland
  3. 3.Alimentary Pharmabiotic CentreUniversity College CorkCorkIreland

Personalised recommendations